$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| FORM 6-K | 19 Mar 2015 |
| COLLABORATION WITH DAIICHI SANKYO INC | 19 Mar 2015 |
| POSITIVE PHASE III RESULTS FOR PT003 IN COPD | 18 Mar 2015 |
| BRILINTA PEGASUS-TIMI 54 STUDY | 16 Mar 2015 |
| FILING OF FORM 20-F WITH SEC | 10 Mar 2015 |
| ANNUAL FINANCIAL REPORT | 10 Mar 2015 |
| ASTRAZENECA REFINES ITS FINANCIAL REPORTING | 06 Mar 2015 |
| AZ TO PARTICIPATE IN US FDA EMDAC | 04 Mar 2015 |
| ACQUISITION OF RIGHTS TO ACTAVIS' PORTFOLIO | 03 Mar 2015 |
| TOTAL VOTING RIGHTS | 02 Mar 2015 |
| PULMICORT RESPULES? US PATENT LITIGATION DECISION | 17 Feb 2015 |
| DIRECTORATE CHANGE | 17 Feb 2015 |
| FINAL RESULTS | 05 Feb 2015 |
| AZ TO ACQUIRE ACTAVIS? US RESPIRATORY PORTFOLIO | 05 Feb 2015 |
| NOTICE OF RESULTS | 04 Feb 2015 |
| TOTAL VOTING RIGHTS | 02 Feb 2015 |
| MAA FOR GOUT TREATMENT LESINURAD ACCEPTED BY EMA | 22 Jan 2015 |
| BRILINTA PEGASUS STUDY MEETS PRIMARY ENDPOINT | 14 Jan 2015 |
| TOTAL VOTING RIGHTS | 02 Jan 2015 |
| LYNPARZA APPROVED BY THE US FDA | 19 Dec 2014 |
